Author Klapper, Wolfram

1 to 20 of 68 Items
  • 2023 | Journal Article
    ​ ​Contrasting Features of T-Cell Expansion in Classical Hodgkin Lymphoma: Tumor Microenvironment Vs. Peripheral Blood and before Vs. during Anti-PD1 Treatment​
    Seifert, N.; Reinke, S.; Grund, J.; Müller-Meinhard, B.; Engert, A.; Borchmann, P. & Bröckelmann, P. J et al.​ (2023) 
    Blood, 142(Supplement 1) pp. 3018​-3018​.​ DOI: https://doi.org/10.1182/blood-2023-186527 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial​
    Braulke, F.; Zettl, F.; Ziepert, M.; Viardot, A.; Kahl, C.; Prange-Krex, G. & Korfel, A. et al.​ (2022) 
    HemaSphere, 6(12) art. e808​.​ DOI: https://doi.org/10.1097/HS9.0000000000000808 
    ​Details  DOI  WoS 
  • 2021 | Journal Article | 
    ​ ​Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas​
    Hübschmann, D.; Kleinheinz, K.; Wagener, R.; Bernhart, S. H.; López, C.; Toprak, U. H. & Sungalee, S. et al.​ (2021) 
    Leukemia, 35(7) pp. 2002​-2016​.​ DOI: https://doi.org/10.1038/s41375-021-01251-z 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​The “Burkitt-like” immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS​
    Hüttl, K. S.; Staiger, A. M.; Richter, J.; Ott, M. M.; Kalmbach, S.; Klapper, W. & Biesdorf, A.-S. et al.​ (2021) 
    Virchows Archiv,.​ DOI: https://doi.org/10.1007/s00428-021-03050-4 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B cell–type diffuse large B-cell lymphoma​
    Thurner, L.; Hartmann, S.; Bewarder, M.; Fadle, N.; Regitz, E.; Schormann, C. & Quiroga, N. et al.​ (2020) 
    Haematologica, pp. haematol.2019.241653​.​ DOI: https://doi.org/10.3324/haematol.2019.241653 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1​
    Reinke, S.; Bröckelmann, P. J.; Iaccarino, I.; Garcia-Marquez, M.; Borchmann, S.; Jochims, F. & Kotrova, M. et al.​ (2020) 
    Blood, 136(25) pp. 2851​-2863​.​ DOI: https://doi.org/10.1182/blood.2020008553 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​High CD206 levels in Hodgkin lymphoma‐educated macrophages are linked to matrix‐remodeling and lymphoma dissemination​
    Arlt, A. ; Bonin, F. ; Rehberg, T.; Perez‐Rubio, P.; Engelmann, J. C.; Limm, K. & Reinke, S. et al.​ (2020) 
    Molecular Oncology, 14(3) pp. 571​-589​.​ DOI: https://doi.org/10.1002/1878-0261.12616 
    ​Details  DOI 
  • 2020 | Journal Article | Research Paper | 
    ​ ​Platform independent protein-based cell-of-origin subtyping of diffuse large B-cell lymphoma in formalin-fixed paraffin-embedded tissue​
    Reinders, J.; Altenbuchinger, M. ; Limm, K.; Schwarzfischer, P.; Scheidt, T.; Strasser, L. & Richter, J. et al.​ (2020) 
    Scientific Reports, 10(1) pp. 7876​.​ DOI: https://doi.org/10.1038/s41598-020-64212-z 
    ​Details  DOI  PMID  PMC 
  • 2019 | Journal Article
    ​ ​MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma​
    Hüllein, J.; Słabicki, M.; Rosolowski, M.; Jethwa, A.; Habringer, S.; Tomska, K. & Kurilov, R. et al.​ (2019) 
    Cancer Research, 79(12) pp. 3125​-3138​.​ DOI: https://doi.org/10.1158/0008-5472.CAN-18-3438 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL​
    Staiger, A. M.; Altenbuchinger, M. ; Ziepert, M.; Kohler, C.; Horn, H.; Huttner, M. & Hüttl, K. S. et al.​ (2019) 
    Leukemia, 34(2) pp. 543​-552​.​ DOI: https://doi.org/10.1038/s41375-019-0573-y 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial​
    König, L.; Dreyling, M.; Dürig, J.; Engelhard, M.; Hohloch, K. ; Viardot, A. & Witzens-Harig, M. et al.​ (2019) 
    Trials, 20(1).​ DOI: https://doi.org/10.1186/s13063-019-3614-y 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​The impact of SOCS1 mutations in diffuse large B‐cell lymphoma​
    Mellert, K.; Martin, M.; Lennerz, J. K.; Lüdeke, M.; Staiger, A. M.; Kreuz, M. & Löffler, M. et al.​ (2019) 
    British Journal of Haematology, 187(5) pp. 627​-637​.​ DOI: https://doi.org/10.1111/bjh.16147 
    ​Details  DOI  PMID  PMC 
  • 2019 | Journal Article | Research Paper | 
    ​ ​Automated macrophage counting in DLBCL tissue samples: a ROF filter based approach​
    Wagner, M.; Hänsel, R.; Reinke, S.; Richter, J.; Altenbuchinger, M. ; Braumann, U.-D. & Spang, R. et al.​ (2019) 
    Biological Procedures Online, 21(1) pp. 13​.​ DOI: https://doi.org/10.1186/s12575-019-0098-9 
    ​Details  DOI  PMID  PMC 
  • 2019 | Journal Article | 
    ​ ​Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma​
    López, C.; Kleinheinz, K.; Aukema, S. M.; Rohde, M.; Bernhart, S. H.; Hübschmann, D. & Wagener, R. et al.​ (2019) 
    Nature Communications, 10(1) art. 1459​.​ DOI: https://doi.org/10.1038/s41467-019-08578-3 
    ​Details  DOI  PMID  PMC 
  • 2019 | Journal Article | 
    ​ ​A modular transcriptome map of mature B cell lymphomas​
    Loeffler-Wirth, H.; Kreuz, M.; Hopp, L.; Arakelyan, A.; Haake, A.; Cogliatti, S. B. & Feller, A. C. et al.​ (2019) 
    Genome Medicine, 11 art. 27​.​ DOI: https://doi.org/10.1186/s13073-019-0637-7 
    ​Details  DOI  PMID  PMC 
  • 2018 | Journal Article
    ​ ​TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma​
    Jethwa, A.; Słabicki, M.; Hüllein, J.; Jentzsch, M.; Dalal, V.; Rabe, S. & Wagner, L. et al.​ (2018) 
    Blood, 131(25) pp. 2789​-2802​.​ DOI: https://doi.org/10.1182/blood-2017-09-806679 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2​
    Horn, H.; Kohler, C.; Witzig, R.; Kreuz, M.; Leich, E.; Klapper, W. & Hummel, M. et al.​ (2018) 
    Haematologica, 103(7) pp. 1182​-1190​.​ DOI: https://doi.org/10.3324/haematol.2017.181024 
    ​Details  DOI 
  • 2018 | Journal Article | Research Paper
    ​ ​Round-robin test for the cell-of-origin classification of diffuse large B-cell lymphoma—a feasibility study using full slide staining​
    Reinke, S.; Richter, J.; Fend, F.; Feller, A.; Hansmann, M.-L.; Hüttl, K. & Oschlies, I. et al.​ (2018) 
    Virchows Archiv, 473(3) pp. 341​-349​.​ DOI: https://doi.org/10.1007/s00428-018-2367-4 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​A New Stromal Signature Applicable to Formalin-Fixed Paraffin-Embedded Tissues Identifies Patients at Risk in Prospective Clinical Trials of the German High-Grade Non-Hodgkin Lymphoma Study Group​
    Staiger, A. M.; Altenbuchinger, M.; Ziepert, M.; Kohler, C.; Horn, H.; Huttner, M. & Huettl, K. et al.​ (2018) 
    Blood, 132(Supplement 1) pp. 343​-343​.​ DOI: https://doi.org/10.1182/blood-2018-99-112450 
    ​Details  DOI 
  • 2018 | Journal Article | 
    ​ ​Cooperative STAT/NF-κB signaling regulates lymphoma metabolic reprogramming and aberrant GOT2 expression.​
    Feist, M.; Schwarzfischer, P.; Heinrich, P.; Sun, X.; Kemper, J.; von Bonin, F. & Perez-Rubio, P. et al.​ (2018) 
    Nature communications, 9(1) art. 1514​.​ DOI: https://doi.org/10.1038/s41467-018-03803-x 
    ​Details  DOI  PMID  PMC 

Researcher

Göttingen All

Sort

issue date

ASC DESC

Items per Page

10 20 50 100